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Psychocial factors, behavioral compliance and survival in urban hemodi-
alysis patients.
Background. The medical risk factors associated with increased mortal-
ity in hemodialysis (HD) patients are well known, but the psychosocial
factors that may affect outcome have not been clearly defined. Psychoso-
cial factors could affect mortality through interaction with patients’
nutrition or their compliance with the dialysis prescription. We conducted
a prospective, longitudinal, multicenter study of urban HD patients to
determine the contribution of compliance and psychosocial factors to
patient survival.
Methods. Patients were assessed using indices of social support, patient’s
assessments of their well-being, including illness effects (IEQ), and
satisfaction with life (SWLS), the Beck Depression Inventory (BDI),
serum albumin concentration, Kt/V and protein catabolic rate (PCR).
Behavioral compliance was measured three ways: percent time actually
dialyzed per treatment compared to prescribed time (shortening behav-
ior); percent sessions attended (skipping behavior) and total integrated
time compliance (% TCOMP). A severity index, previously demonstrated
to be a mortality marker, was used to grade medical comorbidity. The type
of dialyzer the patient was treated with was noted. A Cox proportional
hazards model, controlling for age, medical comorbidity, albumin concen-
tration and dialyzer type was used to assess relative mortality risk of
variations in psychoscial factors and behavioral compliance.
Results. A total of 295 patients (60.8% of those eligible) agreed to
participate. The mean (6 SD) age of our population was 54.6 6 14.1 year,
mean PCR was 1.06 6 0.27 g/kg/day, and mean Kt/V 1.2 6 0.4, suggesting
the patients were well nourished and adequately dialyzed. The patients’
mean BDI was 11.4 6 8.1 (in the range of mild depression). Patients’
SWLS was similar to that of a group of patients without chronic illness.
After a 26 month mean follow-up period, higher levels of perceived social
support, improved perception of the effects of illness and increased
behavioral compliance were significantly associated with decreased rela-
tive mortality risk (0.8, 0.77, and 0.79, respectively), controlled for
variations in patients’ age, severity of illness, serum albumin concentration
and dialyzer type. Variations in depression and Kt/V were not predictors
of mortality during the observation period.
Conclusions. Lower levels of social support, decreased behavioral
compliance with the dialysis prescription, and increased negative percep-
tion of the effects of illness are independently associated with increased
mortality in ESRD patients treated with HD. The effects are of the same
order of magnitude as medical risk factors. Such effects may be attribut-
able to a relationship between a patients’ perception of social support and
effects of illness and behavior, with other factors such as the provision of
better medical care in patients with larger social networks. The mechanism
underlying the relationship of psychosocial factors and compliance and
survival, and the effect of interventions to improve perception of illness,
and increase social support and compliance with the dialysis prescription
in HD patients should be studied.
In chronic medical illnesses, at least two types of risk
factors may effect survival: medical parameters and psycho-
social strengths [1]. The medical determinants of mortality
in patients with end-stage renal disease (ESRD) treated
with hemodialysis (HD) are well appreciated, consisting of
older age, presence of diabetes mellitus, and to a lesser
extent, of comorbid conditions such as cardiovascular and
cerebrovascular disease, cancer, collagen vascular disease
and chronic obstructive pulmonary disease [2]. For the
United States’ ESRD population, African American and
women patients tend to have better survival [2]. The role of
nutrition [3–5] and dose of dialysis administered (Kt/V)
[3–4, 6–8] in improving survival in HD patients has been
increasingly appreciated. Most recently, a study has sug-
gested the type of dialyzer used for chronic patient treat-
ment may have an impact on patients’ survival [9].
Psychosocial variables, such as extent of depression and
social support, and patients’ perceptions of their well-being,
may also be related to outcome in patients with acute and
chronic medical illness [10–13], as well as ESRD patients
treated with HD [14–18]. Such factors may affect compli-
ance with treatment regimens [19]. In patients with ESRD
treated with HD, compliance is multifactorial, consisting at
least of dietary restrictions and compliance with the dialysis
schedule, and therefore, difficult to measure with certainty
[19–22]. The relationship between compliance and mortal-
ity in HD patients has, however, also been poorly under-
stood, partially because there has been no gold standard for
measuring compliance in patients treated for ESRD [19,
21, 22]. We recently established quantitative measures to
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assess the effect of patients’ shortening and skipping treat-
ments, compared with physicians’ prescribed times, and
showed that these were often unrelated to standard bio-
chemical compliance measures used to evaluate HD pa-
tients [21, 22].
The extent of the effect of variations in patients’ psycho-
social status and compliance with the dialysis prescription
on outcome in patients with ESRD treated with HD is
currently undetermined. These issues are potentially im-
portant, since results of recent studies have prompted a
controversy, suggesting that patient outcomes in the U.S.
ESRD program are relatively poor given the medical status
of patients, compared with results from other countries
[23]. The impact of possible effects of psychosocial factors
and patient compliance on survival are also important in
the era of managed care contracting for three reasons.
Insurers must calculate survival risks accurately, medical
determinants of outcome may be less amenable to change
than selected psychoscial factors, and patients may have to
accept responsibility for outcomes that may be largely
under their control.
To investigate the possible influence of psychosocial
factors on survival, we prospectively examined the predic-
tive power of behavioral compliance and psychosocial
variables such as extent of depressive symptoms, patients’
perceptions of their level of social support and well-being,
after controlling for medical risk factors, in inner city
patients with ESRD treated with HD.
METHODS
Patient population and demographics of the study
hemodialysis units
Patient recruitment began September 1, 1992 and con-
cluded March 31, 1996. The observation period ended
September 30, 1996. George Washington University Med-
ical Center’s Ambulatory Dialysis Unit (GWUMC),
Howard University Medical Center’s Dialysis Unit
(HUMC), and the Washington Veterans Affairs Medical
Center Dialysis Unit (VAMC), all in Washington D.C.,
were the study sites. The population of the three units was
primarily composed of African American patients. All
patients enrolled in chronic ESRD HD programs at the
GWUMC, HUMC and VAMC dialysis units were eligible
for the study, with the exception of HIV infected patients,
patients who had a psychiatric diagnosis of psychosis and
patients who scored less than 23 on a mini-mental status
exam [24]. Written informed consent was obtained at
GWUMC and HUMC. Verbal consent was obtained prior
to patients’ enrollment at the VAMC. The study was
approved by the institutional review boards of the three
medical centers. Details regarding our recruitment proce-
dures have been previously reported [21]. Questionnaires
were administered in an interview format by trained per-
sonnel to patients enrolled in the study. Psychosocial
variables were assessed in patients at study entry, and at six
month intervals thereafter. The demographics of our pa-
tient population are delineated in Tables 1 and 2.
MEASURES
Medical risk factors
Comorbidity. Disease severity (age and the presence of
comorbid conditions such as cardiovascular and cerebro-
vascular disease, diabetes mellitus, collagen vascular dis-
ease, malignancy and the type of renal disease) was quan-
tified by the ESRD severity coefficient [15, 25, 26],
previously validated in a large sample of ESRD patients
[25]. The product of age and the relative risk of additional
medical illness, including diabetes mellitus, was used to
derive the coefficient [25], an overall measure of the level
of severity of the patient’s renal and comorbid chronic
illnesses.
Nutritional and dialytic parameters. These included pro-
tein catabolic rate (PCR) and Kt/V, calculated monthly at
GWUMC and HUMC, and quarterly at VAMC using the
percent urea reduction, as outlined by Jindal et al [27]. The
dialyzer used to treat each patient at study entry was noted
and categorized as (1) unmodified cellulose (Group 1) or
(2) modified cellulose or synthetic (Group 2) [9]. The mean
of three sequential monthly serum albumin concentrations
after enrollment was determined. Mid-arm circumference
Table 1. Demographics of hemodialysis sample
Site N Male Female White
African
American Hispanic Other
GWU 93 58 35 11 77 2 3
HUH 111 61 50 3 106 1 1
VAMC 91 90 3 5 83 1 2
Total 295 209 88 19 266 4 6
Abbreviations are in the Appendix.
Table 2. Clinical medical and psychosocial characteristics of the study
population (N 5 295)
Mean SD Range
Age, years 54.6 14.13 19–84
Diabetes, % 42.3 — —
Albumin, g/dl 3.82 0.49 2.0–5.7
Kt/V 1.2 0.4 0.36–1.96
PCR, g/kg/day 1.06 0.27 0.49–2.37
MAC, cm 30.2 5.9 15.9–55.7
BDI 11.4 8.1 0–47
MSP 22.1 4.5 5.7–28
IEQ 64.4 26.3 6–140
SWLS 21.7 7.9 5–35
Time compliance % 97.8 2.9 83.3–100
Attendance % 98.3 6.1 38.8–100
Total time compliance % 95.9 7.0 36.4–100
Abbreviations are: PCR, protein catabolic rate; MAC, mean arm
circumference; BDI, Beck Depression Inventory; MSP, Multidimensional
Scale of Perceived Social Support; SWLS, Satisfaction with Life Scale;
Time compliance, shortening behavior; Attendance, skipping behavior;
Total time compliance, integrated shortening and skipping behavior.
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(MAC) and arm muscle area (AMA) measurements were
obtained by trained personnel at study entry, as previously
described [21, 28, 29].
Psychosocial variables
Depression. The Beck Depression Inventory (BDI) was
used to measure depressive symptoms [30]. The BDI is a
well-validated measure of depression, correlating with di-
agnostic criteria for depression [30], and has been used
frequently to assess depression in patients with ESRD [14,
15, 21, 26, 31]. A second measure, the Cognitive Depres-
sion Index (CDI), was composed of 15 of the 21 items of
the BDI [14, 15, 26]. The CDI focuses on thoughts and
feelings related to the diagnosis of depression, such as guilt,
disappointment and failure, and excludes somatic items [14,
26]. The CDI has previously been highly correlated with the
BDI and mortality in ESRD patients [14, 15, 21, 26].
Social support. Social support is multidimensional infor-
mation related to an individual as a member of a complex
network in which one can give and receive affection, aid,
and obligation [10, 32–36]. The Multidimensional Scale of
Perceived Social Support (MSP) [35] is a 12 item inventory
that assesses overall perceived social support from special
persons, family and friends. A special person is someone
who may serve a special multi-support role but may not be
a family member or friend, such as a clergyman, health care
worker, coworker, or confidant. Each of these sources of
support are factorially independent [35]. The MSP scale
has demonstrated good internal and test-retest reliability
[35]. The mean of the three factor scores reported by a
patient were added to obtain a total social support score
(MSPTOT), as used by our group previously [21, 36].
Well-being measures
Perception of illness effects. The Illness Effects Question-
naire [37, 38] is a 20 item, seven point Likert scale that
assesses the individual’s perception of how the illness
interferes with or modifies personal and social behavior.
Questions range from perceived family and personal dis-
ruption to physical problems and fears about the conse-
quences of illness. The IEQ has an internal reliability of a
5 0.93, and a test-retest reliability of 0.99, and has been
used in patients with ESRD [15, 21, 26, 32, 36]. Higher
scores indicate greater levels of perceived life disruption
from illness. The IEQ has previously been highly correlated
with the BDI and the CDI [15, 21, 26, 36].
Quality of life. The Satisfaction with Life Scale (SWLS) is
a five item scale with a 1 to 7 (low to high) satisfaction
rating for each item [39, 40]. The items ask about ideal life,
conditions of life and satisfaction with present and past life.
Diener et al reported good internal reliablity, two month
test-retest reliability and moderate correlations with a large
number of subjective well-being scales, and lack of corre-
lation with social desirability [39]. The SWLS has been used
as a general global, subjective quality of life measure, as
previously reported in patients treated with HD [36].
Behavioral compliance
Patients’ behavioral compliance with their prescribed
HD regimen was assessed using three scales, as previously
described [21]: (1) Percent Time Compliance (% COMP)
measured the amount of time the patient was actually
dialyzed compared to the time physicians prescribed, only
for sessions attended by the patient. This quantifies the
amount of time patients decrease the length of dialysis
sessions, characterizing “shortening” behavior. (2) Percent
Attendance (% ATTEND) comprised the number of ses-
sions attended compared to the number prescribed, quan-
tifying the percentage of sessions from which the patient
was absent without excuse (such as being hospitalized or
receiving treatment as a transient patient in another unit),
characterizing “skipping” behavior. (3) Total Time Com-
pliance (% TCOMP) reflects the percent time the patient
received dialysis compared to the total time prescribed in
both attended and unattended sessions, an overall measure
of compliance with the dialysis prescription, including
“skipping” and “shortening” behaviors. The resulting val-
ues were averaged over a three month period, beginning
with the date of study entry. Individual behavior compli-
ance measures are highly stable over time [21].
Statistical methods
Correlations between psychosocial variables and age,
medical risk factors, including demographic data, and
behavioral compliance levels were assessed using Spear-
man Rank Order coefficients, as previously described [21,
36], because the behavioral compliance measures all dis-
played skewed distributions. Stability of psychosocial vari-
ables was assessed by correlating individuals’ values at
baseline, six month and at one year follow-up, as previously
described [21]. Differences between groups were assessed
by unpaired t-tests, chi-square analysis and analysis of
variance as appropriate.
Survival time for each individual patient was determined
both by the number of days between first dialysis and the
end of the study observation period, or date of death, and
initial study evaluation and the end of the study observation
period or date of death. Survival status was confirmed using
the Health Care Finance Administration data base, ob-
tained through ESRD Network 5 (Richmond, Virginia) for
all patients enrolled in the study. Cox proportional hazards
regression was used to predict mortality hazard [41]. A
separate equation was calculated for each medical and
demographic predictor (age at time of entry into the study,
gender, severity coefficent, serum albumin concentration,
dialyzer type, and Kt/V).
Following the results of these initial bivariate Cox regres-
sions, regression analyses were performed in which the
relationship between compliance indicators, psychosocial
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and well-being variables, and survival were examined while
simultaneously controlling for the effects of variation in
levels of medical risk factors, specifically patients’ age,
severity coefficient, level of serum albumin concentration
and dialyzer type. Relative risks or hazards represent the
expected change in mortality risk associated with a one SD
increase in the predictor variable, except for dialyzer type
and gender, or as otherwise noted. This allows for compar-
ison of the effects of changes in levels of several risk factors
across different parameters in a population [42]. Analyses
were performed using PROC PHREG in SAS 6.11 (SAS
Institue Inc., Cary, NC, USA). The alpha level of tests of
survival and group differences was 0.05. Data are presented
as mean 6 SD.
RESULTS
Demographics
The total enrolled sample surveyed comprised 295 sub-
jects, a 60.8% overall enrollment rate. Mean and median
follow-up times were 26.4 6 12.8 and 27.7 months, respec-
tively. Nearly all (90.2%) of our patient population was
comprised of African Americans (Table 1); 29.8% of the
patients were female, and 42.3% had diabetes mellitus.
Medical risk factors
The mean age of our patient population was 54.6 6 14.1
years old (Table 2). Patients had been treated with hemo-
dialysis for mean and median times of 56.6 6 51.9 and 41.5
months, respectively. The patients’ mean PCR was 1.06 6
0.27 g/kg/day and mean Kt/V was 1.2 6 0.4. The mean
serum albumin concentration in our patient population was
3.82 6 0.49 g/dl. Anthropometric evaluations were per-
formed in two hundred forty-seven of the subjects (83.7%).
Anthropometry could not be performed in 48 subjects,
because of disability associated with cerebrovascular dis-
ease, refusals, transfers from the unit, or because of death
before assessment. The patients’ mean arm circumference
was 30.2 6 5.9 cm. These findings suggest the patients were
well-nourished (compared with a normative cohort of
patients with ESRD treated with HD [43]) and delivery of
dialysis (Kt/V) was adequate [44].
A total of 43.0% of patients were treated with unmodi-
fied cellulose, 12.6% with modified cellulose and 44.4%
with synthetic dialyzers. Specifically, 92.7% of patients at
the VAMC, 54.4% of patients at GWUMC, and 1.0% of
patients at HUMC were treated with synthetic dialyzers,
whereas 7.3% of patients at the VAMC, 30.4% of patients
at GWUMC and 75.0% of patients at HUMC were treated
with unmodified cellulose dialyzers. There was no differ-
ence between the mean age or the proportion of patients
with diabetes mellitus treated with each type of dialyzer.
Fewer women were treated with synthetic, and more were
treated with unmodified cellulose dialyzers, in part because
of the lower proportion of women treated at the VAMC.
The mean serum albumin concentration was lower in
patients treated with modified cellulose compared with
unmodified cellulose and synthetic dialyzers (3.5 6 0.43 vs.
3.8 6 0.51, and 3.9 6 0.43 g/dl, P , 0.0001, ANOVA).
Mean Kt/V was significantly higher in patients treated with
synthetic (1.3 6 0.34), compared with unmodified (1.2 6
0.27) or modified cellulose dialyzers (1.2 6 0.31, P , 0.006,
ANOVA). There was no difference between mean levels of
age, BDI, CDI, SWLS, IEQ, MSPTOT, or behavioral
compliance parameters in patients treated with different
types of dialyzers.
Psychological and compliance data
The mean BDI score for the entire population was
11.4 6 8.1, in the range of mild depression (Table 2) [30].
The mean MSPTOT score was 22.1 6 4.5, which is similar
to university student normative samples [45]. The patients’
mean IEQ score was 64.4 6 26.3, which is comparable to
scores for a general medical inpatient sample, and samples
of patients with arthritis and chronic pain [46]. The pa-
tients’ mean SWLS score was 21.7 6 7.9, which is compa-
rable to normative adult samples [40]. Behavioral compli-
ance data were available for 292 (99%) of the patients. The
mean percent time compliance was 97.8 6 2.9%, with a
range of 83.3 to 100%. The mean percent attendance was
98.3 6 6.1%, with a range of 38.8 to 100%, and the mean
total time compliance was 95.9 6 7.0%, with a range of 36.4
to 100%. These averages are comparable to those previ-
ously reported by others [47, 48].
Stability of psychosocial measures
Patients’ individual baseline, six-monthly and one year
social support, IEQ, SWLS, BDI and CDI scores correlated
highly (r range 0.50 to 0.83, all P , 0.001), indicating high
stability over time.
Correlations of medical, psychosocial and compliance
data
Increased patient age was associated with an increased
severity coefficient (r 5 0.94, P 5 0.0001), higher SWLS
scores (r 5 0.27, P 5 0.0001), less shortening and skipping
behavior and improved total time compliance (r 5 0.23,
P 5 0.0001, r 5 0.17, P 5 0.004, r 5 0.27, P 5 0.0001,
respectively), but with no other psychosocial variables
(Table 3). Increased severity coefficient scores were asso-
ciated with higher SWLS scores (r 5 0.22, P 5 0.0001), as
seen in previous studies of patients with ESRD and in other
populations [36], as well as less shortening and skipping
behavior and improved total time compliance (r 5 0.18,
P 5 0.002, r 5 0.16, P 5 0.006, r 5 0.23, P 5 0.0001,
respectively). No psychosocial parameter correlated with
serum albumin levels. The psychological and social vari-
ables tended to be highly intercorrelated (as previously
reported [21, 36]; data not shown). Increased BDI and CDI
scores, connoting worsened depression, correlated with
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worsened total time compliance (r 5 20.12, P 5 0.04, r 5
20.13, P 5 0.026, respectively) but not with shortening or
skipping behavior. More negative IEQ scores (connoting
increased perception of disruptive effects of illness) were
associated with worsened attendance (r 5 20.12, P 5 0.04),
but not with other behavioral compliance scores. Increased
SWLS scores were associated with improved attendance
and total behavioral compliance (r 5 0.16, P 5 0.005, r 5
0.13, P 5 0.027). MSPTOT scores did not correlate with
any behavioral compliance measure.
Survival analyses
A Cox regression applied to the entire sample confirmed,
as expected, a 40% increased mortality risk for each decade
increase in age (P , 0.0001; data not shown). There was a
65% and 67% increased mortality risk for each one SD
increase in age and severity coefficient, respectively (P ,
0.0001, Table 4). There was a 24% decrease in mortality
risk for each one SD increase in patients’ serum albumin
concentration (P , 0.01, Table 4), and a 50% decrease in
risk for each 1 g/dl increase in albumin concentration,
controlling for age and severity coefficient (P , 0.01, data
not shown). No association was present between mortality
risk and gender or level of Kt/V, with or without controlling
for age and/or severity coefficient, in this comparatively
small population.
There was no difference in the mean value of any
assessed parameter between patients treated with unmod-
ified cellulose dialyzers (Group 1) compared with those
treated with modified cellulose and synthetic dialyzers
(Group 2). The difference between the mean levels of Kt/V
between patients treated with Group 1 and 2 dialyzers
approached but did not reach the level of significance (P 5
0.0514, unpaired t-test). There was no difference in the
proportion of patients with diabetes mellitus treated with
these two different categories of dialyzers, although a
greater proportion of women were treated with unmodified
cellulose dialyzers (P 5 0.001, Chi square), and the pro-
portion of patients treated with different types of dialyzers
varied between the different study sites. Patients treated
with modified cellulose and synthetic dialyzers had a 35%
decreased mortality risk compared with those treated with
unmodified cellulose dialyzers, with (data not shown) and
without controlling for severity coefficient (both P 5 0.04,
Table 4).
Finally, the effects of variation in compliance and psy-
chosocial parameters were tested. In each case, patients’
age, severity coefficient, level of serum albumin concentra-
tion and dialyzer type were entered in the Cox regression
first, and thus controlled for prior to testing for compliance
and psychosocial effects. A one SD improvement in percent
time compliance and total time compliance was associated
with a 24% and 21% reduction in relative mortality risk
(C.I. 0.62 to 0.91, 0.66 to 0.95, respectively, both P , 0.01,
Table 5). The 13% decreased mortality risk associated with
improved attendance at dialysis sessions did not, however,
reach the level of statistical significance.
Table 3. Correlation matrix of selected medical and psychosocial factors
BDI MSP IEQ SWLS SEV SAlb %COMP %ATTEND %TCOMP
Agea 20.05 0.03 0.004 0.27 0.94 20.08 0.22 0.17 0.27
0.40 0.67 0.95 0.0001 0.0001 0.16 0.0001 0.004 0.0001
SEVb 20.02 20.06 0.03 0.22 — 20.09 0.18 0.16 0.23
0.75 0.33 0.59 0.0001 — 0.13 0.002 0.006 0.0001
SAlb 20.06 20.04 20.03 20.07 20.09 — 20.08 0.04 20.03
0.28 0.51 0.62 0.21 0.13 — 0.16 0.48 0.63
Kt/V 20.02 20.04 20.07 0.04 0.09 20.008 20.04 0.04 20.001
0.72 0.49 0.29 0.52 0.14 0.16 0.55 0.47 0.98
%COMP 20.08 20.005 20.07 0.07 0.18 20.08 — 0.11 0.78
0.13 0.93 0.24 0.21 0.002 0.17 — 0.05 0.0001
%ATTEND 20.09 0.11 20.12 0.16 0.16 0.04 0.11 — 0.63
0.12 0.07 0.04 0.005 0.006 0.48 0.05 — 0.0001
%TCOMP 20.12 0.04 20.10 0.13 0.23 20.03 0.78 0.11 —
0.04 0.54 0.08 0.03 0.0001 0.63 0.0001 0.05 —
Abbreviations are: BDI, Beck Depression Inventory; MSP, Multidimensional Scale of Perceived Social Support, total score; IEQ, Illness Effects
Questionnaire; SWLS, Satisfaction with Life Scale, total score; SEV, Severity Coefficient; S
Alb
, Serum albumin concentration, g/dl; Kt/V, delivered dose
of dialysis; %COMP, percent time on dialysis (inverse of shortening behavior); %ATTEND, percent attendance (inverse of skipping behavior);
%TCOMP, total time compliance.
a r
b P value
Table 4. Predicting mortality from medical and demographic risk
factors
Risk factors RR (95% C.I.) P
Age 1.65 (1.33, 2.04) ,0.0001
Severity coefficient 1.67 (1.37, 2.02) ,0.0001
Serum albumin concentration 0.76 (0.62, 0.93) ,0.01
Gender 1.00 (0.64, 1.55) 0.99
Kt/V (3 month mean) 0.95 (0.77, 1.18) 0.67
Dialyzer type 0.65 (0.43, 0.98) 0.04
Abbreviations are: RR, Risk Ratio; C.I., Confidence Interval. All
variables are standardized to a standard deviation of 1.0, except for the
two binary predictors (dialyzer and gender). Dialyzer types are detailed in
the text.
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There was no association between the level of either
depression index and relative mortality risk. In contrast, a 1
SD increase in patients’ perception of social support was
associated with a 20% decrease in relative mortality risk,
after controlling for age, severity of comorbid illness, level
of serum albumin concentration and dialyzer type (C.I. 0.65
to 0.98, P 5 0.03, Table 5). A 1 SD increase in IEQ score
(denoting an increased patient perception of disruptive
effects of illness) was associated with a 23% increase in
relative mortality risk, controlling for age, severity of
comorbid illness, level of serum albumin concentration and
dialyzer type (C.I. 1.00 to 1.51, P 5 0.05). There was a trend
towards association of increased satisfaction with life scores
with improved survival, but the level of statistical signifi-
cance was not achieved.
Similar results were obtained when survival time for each
patient was determined both by the number of days be-
tween first dialysis and the end of the study observation
period, or date of death (data not shown). In general, these
relationships persisted when controlled for site, with the
exception of the association between dialyzer type and
survival.
DISCUSSION
Medical factors and mortality
As expected, age and severity of illness were associated
with mortality in our population. Serum albumin concen-
tration, an indicator of nutritional status, was also related
to improved survival, as noted by others [2–5]. Surprisingly,
Kt/V was not associated with survival in this study. This may
be due to our relatively small sample size, or because of its
lesser relationship to patient survival [3]. Kt/V has been
noted to be a correlate of survival, but only in very large
samples with long follow-up times. In addition, Kt/V, as
used clinically, may not provide an adequate description of
the actual delivery of dialysis over time. A study performed
only during 1/13 of treatments (or 2% of the time when the
determination is performed quarterly), on a day when the
patient knows post-dialytic chemistries will be ascertained,
may only provide a “snapshot” of that particular treatment.
Kt/V therefore may not correlate with the actual delivery of
dialysis over time, which is dependent on the patient’s
adherence to the dialysis prescription. Indeed, this was the
case in this study, where Kt/V did not correlate with
measured behavioral compliance parameters.
In this prospective study, we confirm the findings of
Hakim et al regarding the association of survival and
dialyzer type [9]. While there was a trend to lower levels of
Kt/V in patients treated with unmodfied cellulose dialyzers
compared with those treated with modified cellulose and
synthetic dialyzers, the difference between the values did
not achieve the level of statistical significance. In addition,
the only differences between groups of patients treated
with various dialyzer types in all the assessed parameters
were gender and site differences. To our surprise, however,
in contrast to the other medical and psychosocial risk
factors, the dialyzer effect was not significant when con-
trolled for site. These findings suggest, besides clearance
and the parameters suggested by Hakim et al, that specific
site factors may be associated with the differential mortality
seen in patients dialyzed with different dialyzers. This
suggests that disparities in mortality are not necessarily
related to characteristics of the membrane (and patient/
membrane interactions), but may be due to physician or
unit factors, including the manner in which the membranes
are used, including water treatment protocols, which may
ultimately be the proximate cause of variations in outcome
[49]. Such notions must be assessed in carefully planned,
multicenter, randomized, prospective controlled studies.
Psychosocial factors and mortality
Depression. We had hypothesized depression would be
related to patients’ poorer survival, potentially mediated
through changes in compliance and nutrition. In this study,
we could not demonstrate an association of depressive
symptoms with survival, although depression was corre-
lated with various psychosocial factors and with decreased
behavioral compliance parameters. Thus, we were unable
to replicate the previously reported association of depres-
sion and mortality [15]. The present results, however, are
consistent with those of another study [16]. Additional
research is needed regarding the relationship of depression
and mortality, which may only hold with short-term predic-
tions [14, 15], or in samples which include large numbers of
very depressed patients.
Social support. Our study supports the hypothesis that
social support is related to mortality among chronically ill
patients, in particular among inner city African Americans.
That social support can significantly add to the prediction
of mortality when a large number of medical variables are
controlled suggests its very robust effects. Our findings are
consistent with the view that social support is an important
factor in general health outcome and adjustment to chronic





% Time compliance 0.76 (0.62, 0.91) ,0.0001
% Attendance 0.87 (0.72, 1.05) 0.15
% Total time compliance 0.79 (0.66, 0.95) 0.01
Beck Depression Inventory 1.05 (0.87, 1.27) 0.59
Cognitive Depression Index 1.03 (0.85, 1.26) 0.73
Illness Effects Questionnaire 1.23 (1.00, 1.51) 0.05
Social Support (MSP) 0.80 (0.65, 0.98) 0.03
Satisfaction with Life Scale 0.83 (0.66, 1.04) 0.10
Abbreviations are: RR, Risk Ratio; C.I., Confidence Interval. All
variables are standardized to a standard deviation of 1.0, so that the RR
represents the expected change in mortality risk associated with a one
standard deviation change in the risk factor. All relative risks are
controlled for variations in patients’ age, severity coefficient, serum
albumin concentration, and dialyzer type. Details are in the text.
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and acute illness [10, 13, 16]. Indeed, lack of social support
has been associated with increased mortality and morbidity
in several studies from the U.S. and abroad, in populations
with different chronic illnesses characterized by differing
geographic settings, socioeconomic status and ethnic back-
grounds [10]. High levels of social support have been
associated with increased use of cancer screening services
in older African-American patients [50]. Other studies have
shown support from friends and others was independently
related to survival in women with breast cancer [51, 52].
Associations between indicators of social support and
survival have also been demonstrated in recent studies of
patients with ESRD [16, 53–57]. McClellan and colleagues
showed, in a prospective study, that a quality of life
measure, which included social support, predicted survival
of HD patients [53]. Christensen et al showed family
cohesion, as a social support indicator, was significantly
associated with survival, independent of age, in a study of
78 in-center hemodialysis patients [16]. In the latter study,
standard compliance parameters such as level of predialysis
serum potassium, phosphorus, or interdialytic weight gain
[21, 22] were not associated with survival. In both these
studies, however, the effects of other various potential
medical risk factors, including nutritional status, delivery of
dialysis and quantitative compliance with the dialysis regi-
men were not assessed. In a recent study, McClellan and
colleagues showed patients’ assessment of level of giving
social support was related to improved survival in a cohort
of patients with ESRD treated with HD [57]. The relation-
ship of social support to other medical and psychosocial
parameters, however, was not explored in that study [57].
Although the association between social support and
improved survival of patients with chronic illness is consis-
tent in varying populations, the mechanisms underlying the
association are unknown [10, 58]. One study in HD patients
suggested that family support was related to compliance,
assessed by standard compliance measures [54]. Most pre-
vious studies, however, did not include longitudinal reap-
praisals of psychologic or compliance parameters. In this
study, we have demonstrated the stability of psychosocial
factors over a period of several months after patients’ initial
assessment. Additionally, we found social support was
related to extent of depressive symptoms, perception of
illness effects and satisfaction with life in this study. Pa-
tients with high levels of social support may have increased
access to health care providers, dialysis facilities and overall
better health care habits. Also, the tendency of people with
higher social support to having better mood, less perceived
disruption from their illness and a better perceived quality
of life may affect medical and biochemical factors in
unknown ways. Social support, however, was not related to
behavioral compliance measures in this study.
Perception of illness. Patients’ perceptions of the intru-
siveness of their illness was also associated with their
poorer survival in this study. Models of coping with chronic
illness suggest perception of illness may be as or more
important to adjustment and coping with illness than its
medical severity [38, 59]. Consistent with previous findings,
perceived illness effects were not associated with severity of
illness in the present study. This finding is in agreement
with reports that perception of illness effects may not only
be an important predictor of outcome, but, as a coping
mechanism, may be amenable to change [59]. Patients’
perception of their well-being, an important component of
quality of life [36, 60], is easily assessed and might form an
important part of the medical evaluation. Indeed, a recent
study suggests patients’ perceptions of their physical func-
tional capacity were predictive of survival [61].
Compliance. We have demonstrated a relationship be-
tween behavioral compliance with the dialysis prescription
and survival, above and beyond the effect of medical risk
factors. This is particularly important because behavioral
compliance should contribute to increased levels of nutri-
tion and Kt/V over time. Few studies have employed time
of dialysis delivery compared with prescribed time as a
measure of compliance [21, 22, 36, 47, 48]. This approach
provides a clear behavioral measure of patient compliance,
in contrast to standard compliance measures [19]. We have
previously shown behavioral compliance measures are, on
the whole, largely unrelated to standard compliance mea-
sures [21, 22, 36]. Such findings suggest compliance in HD
patients is comprised of several aspects, such as dietary
behaviors, compliance with prescribed medication regi-
mens and behavioral components, such as attendance at
dialysis sessions. We have also previously demonstrated, in
this study population, that patients’ adherence to the
dialysis prescription is stable, consistent, and typifies an
individual subject over an extended time period [21].
In the present study, with a longer observation period, we
have now demonstrated that psychosocial factors tend to
remain stable in patients over one year. However, percep-
tion of social support from family, friends and others was
not associated with patients’ illness severity, or extent of
behavioral compliance. In contrast, perception of illness
intrusiveness was variably associated with several behav-
ioral compliance measures. These findings are inconsistent
with the idea that more severe medical illness leads to
lower levels of perceived social support and decreased
perception of well-being. They do support the notion that
perception of well-being may exert its effects on survival
through changes in compliance with the dialysis prescrip-
tion.
Alternatively, the effects of perceptual variables and
social support may be mediated through altered nutrition,
or by affecting the psychoneuroimmunologic system [14,
59, 62], perhaps by reducing the effects of stress. Previous
studies have suggested an interrelationship between psy-
chological status, immune dysfunction, nutrition and out-
come [14, 59, 62] However, patients’ MSPTOT scores were
not related to nutritional factors such as level of serum
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albumin, mean upper arm circumference, or arm muscle
area, standard anthropometric measures of malnutrition in
this population [5, 43].
We could not demonstrate a relationship between behav-
ioral compliance and Kt/V, the measure of the delivered
dose of dialysis. Indeed, Kt/V represents the delivered dose
of dialysis only if the patient complies with the prescription
each and every treatment. Since psychosocial and well-
being indices, and Kt/V were unrelated to measures of
behavioral time compliance, it appears that this measure of
adherence to the dialysis prescription, which is related to
survival, may be both an important characteristic that may
typify a patient [21], and an independent mechanism that
influences mortality.
In this study, perception of extent of social support, level
of well-being and improved behavioral compliance were
associated with changes in the relative risk of mortality in
the range of the magnitude of effects that age, severity of
comorbid illness and serum albumin displayed [42]. Many
medical risk factors are not easily altered in patients with
ESRD. Although behavioral compliance with the dialysis
prescription was associated with improved survival, we
could not demonstrate an association of these parameters
with Kt/V, the measured “dose” of dialysis. While improved
behavioral compliance with the dialysis prescription will
undoubtedly be associated with increased delivery of dial-
ysis, our study may not have had enough power to detect
such variations. Alternatively, compliance styles may reflect
personality traits or social factors associated with improved
survival. Our population had a relatively high Kt/V [44] and
adequate nutritional status [43]. The effect of increasing
dose of dialysis may be only appreciated in relatively large
populations with longer follow-up. Additionally, there may
be diminished returns of increasing delivery of dialysis
when the Kt/V is already relatively high. Such questions are
currently being addressed in prospective studies. However,
differing psychosocial, perceptual and well being, and com-
pliance factors, rather than medical or dialytic ones may be
associated with the differential survival in patients in other
countries that is currently of concern to national health
policy makers [23].
Our study population was primarily comprised of male,
African American, urban patients. In previous work, we
demonstrated the relationship of psychosocial variables to
behavioral compliance may be different in dialysis units
with different patient populations, including those with
differing gender composition, type of hemodialysis admin-
istered and dialyzers used, and mean prescribed dialysis
time [21]. The present association of improved social sup-
port and perception of well-being with improved survival
does not necessarily imply causality. Although MSPTOT
and IEQ levels were not correlated with medical severity,
other unknown mediating factors may be associated with
both level of social support and perception of well-being
and medical factors that affect outcome.
Our findings, while consistent with those documented in
ESRD patients and those with other chronic diseases, must
be replicated in larger and more diverse populations to
establish the generalizable and specific outcomes reported.
Another way to demonstrate causality would be to docu-
ment the effect of a psychosocial intervention on survival in
a population at risk. The first 25 years of the ESRD
program were largely devoted to identifying and minimiz-
ing the medical risk factors associated with poor patient
survival. The next step is to modify factors, such as percep-
tions of illness, level of social support and extent of
behavioral compliance with the dialysis prescription, which
are remediable or are under the patients’ control, in an
attempt to improve both their quality and length of life. We
should listen to our patients’ perceptions of how their
ESRD variably affects their lives—they may be telling us
about their mortality risk. We should continue our efforts
to encourage both patient compliance with the dialysis
prescription and with dietary regimens. The effect of
interventions to increase behavioral and dietary compliance
with the dialysis prescription, social support, and percep-
tions of well-being, and their effect on survival in hemodi-
alysis patients should be studied further.
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APPENDIX
Abbreviations used in this article are: AMA, arm muscle area;
%ATTEND, percent attendance; BDI, Beck Depression Inventory; CDI,
Cognitive Depression Index; %COMP, percent time compliance; ESRD,
end-stage renal disease; GWUMC, George Washington University Med-
ical Center; HD, hemodialysis; HUMC, Howard University Medical
Center; IEQ, Illness Effects Questionnaire; Kt/V, delivery of dialysis;
MAC, mid-arm circumference; MSP, Multidimensional Scale of Perceived
Social Support; MSPTOT, total social support score; PCR, protein
catabolism rate; SWLS, Satisfaction with Life Scale; VAMC, Veteran’s
Administration Medical Center.
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